Cholesterol &
Lipids Panel
What Is a Cholesterol & Lipids Panel?
A cholesterol and lipids panel is a blood test that measures the fats circulating in your bloodstream — their type, concentration, and the balance between them. It is one of the most important tests for assessing your long-term cardiovascular risk, providing information that a total cholesterol figure alone simply cannot.
Cholesterol itself is not inherently harmful — it is an essential molecule involved in cell membrane structure, hormone production, and vitamin D synthesis. The problem arises when certain types of cholesterol-carrying particles accumulate in the walls of arteries, forming plaques that narrow blood vessels and increase the risk of heart attack and stroke. The key distinction is not just how much cholesterol you have, but what is carrying it — and in what direction.
LDL cholesterol (low-density lipoprotein) is the primary atherogenic fraction — the particles most associated with plaque formation. HDL cholesterol (high-density lipoprotein) is generally protective, transporting cholesterol away from arterial walls and back to the liver. Triglycerides — a separate type of blood fat — add further cardiovascular risk, particularly when elevated alongside low HDL. And ApoB (apolipoprotein B), increasingly recognised as the most accurate single marker of cardiovascular risk, measures the total number of atherogenic particles directly — capturing what LDL alone can miss.
Cardiovascular disease remains the leading cause of death in the UK, accounting for around 160,000 deaths per year. Dyslipidaemia — abnormal lipid levels — is one of the most common and most modifiable contributing factors. In many people, it is entirely asymptomatic until a cardiac event occurs. Testing is the only way to know.
What Does a Lipids Panel Include?
Low-density lipoprotein — the primary driver of atherosclerosis. LDL particles deposit cholesterol into arterial walls, forming plaques. It is the main target of statin therapy and the most commonly used marker for cardiovascular risk management in UK clinical practice.
High-density lipoprotein — the protective fraction. HDL particles transport cholesterol away from arterial walls to the liver for disposal. Low HDL is an independent cardiovascular risk factor, particularly in combination with elevated triglycerides and a large waist circumference.
The sum of all cholesterol-carrying fractions. Used in cardiovascular risk calculators such as QRISK3 alongside other factors. A useful screening marker, but limited in isolation — a high total cholesterol driven mainly by high HDL carries very different risk to one driven by high LDL.
Total cholesterol minus HDL — captures all atherogenic fractions including LDL, VLDL, IDL, and Lp(a). Considered a more reliable risk marker than LDL alone in people with high triglycerides or metabolic syndrome, as it does not rely on the Friedewald equation for calculation.
Blood fats derived primarily from dietary carbohydrates and alcohol, and from excess caloric intake stored as fat. Elevated triglycerides are associated with insulin resistance, metabolic syndrome, and cardiovascular risk — particularly when combined with low HDL. Significantly affected by recent food intake; fasting samples give the most reliable result.
Apolipoprotein B — one protein is present on every atherogenic lipoprotein particle (LDL, VLDL, IDL, Lp(a)). ApoB therefore directly measures the total number of particles capable of entering arterial walls, not just the cholesterol they contain. Increasingly regarded as the most accurate single marker of cardiovascular risk — particularly important in people with normal LDL but elevated particle count.
Total cholesterol divided by HDL — a summary measure of the balance between atherogenic and protective fractions. Used in QRISK3 cardiovascular risk scoring and provides a quick read on whether the overall cholesterol balance is favourable or not.
Lipoprotein(a) — a genetically determined lipoprotein particle that carries additional cardiovascular and thrombotic risk independent of LDL. Around 1 in 5 people carry elevated Lp(a) without knowing it. It does not respond meaningfully to statins or lifestyle change, making identification important for specialist management. Included in extended panels.
When Should You Get a Lipids Panel?
What's Involved in Getting a Lipids Panel
A lipids panel requires only a small blood draw. Fasting is recommended for the most accurate triglyceride measurement. Here is what the process will look like end to end when we launch.



What Do Your Lipid Results Mean?
Individual lipid values are meaningful — but cardiovascular risk is determined by the pattern across the full panel, combined with other risk factors. Here are the most clinically important patterns and what they typically indicate.
Could You Have Familial Hypercholesterolaemia?
People with FH have LDL levels that lifestyle changes alone cannot meaningfully control. Without treatment, they are at significantly elevated lifetime risk of premature cardiovascular disease — including heart attacks in their 30s and 40s. Statin therapy started early dramatically reduces that risk, but only if the diagnosis has been made.
